|
The
summary of the Company’s total Stock Option Plans as of March 31, 2022 and March 31, 2021, and changes during the periods then
ended, are presented below. The Company’s Plans consist of the 2010 Stock Option Plan, the 2017 Plan and the 2003 Outside Directors
Stock Plan (“2003 Plan”):
Schedule of Stock Options Roll Forward
| |
|
Shares |
|
|
Weighted Average
Exercise
Price
|
|
|
Weighted Average Remaining Contractual Term
(years)
|
|
|
Aggregate Intrinsic
Value (3)
|
|
| Options outstanding January 1, 2022 |
|
|
1,019,400 |
|
|
$ |
4.91 |
|
|
|
|
|
|
|
— |
|
| Granted |
|
|
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
— |
|
|
$ |
—
|
|
|
|
|
|
|
$ |
—
|
|
| Forfeited/expired |
|
|
— |
|
|
$ |
—
|
|
|
|
|
|
|
|
|
|
| Options outstanding end of period (1) |
|
|
1,019,400 |
|
|
$ |
4.91 |
|
|
|
3.8 |
|
|
$ |
1,150,167 |
|
| Options exercisable at March 31, 2022(1) |
|
|
455,900 |
|
|
$ |
3.92 |
|
|
|
2.5 |
|
|
$ |
779,362 |
|
| |
|
Shares |
|
|
Weighted Average
Exercise
Price
|
|
|
Weighted Average Remaining Contractual Term
(years)
|
|
|
Aggregate Intrinsic
Value (3)
|
|
| Options outstanding January 1, 2021 |
|
|
658,400 |
|
|
$ |
3.87 |
|
|
|
|
|
|
|
— |
|
| Granted |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
$ |
— |
|
| Forfeited/expired |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
| Options outstanding end of period (2) |
|
|
658,400 |
|
|
$ |
3.87 |
|
|
|
3.2 |
|
|
$ |
2,279,267 |
|
| Options exercisable at March 31, 2021(2) |
|
|
392,400 |
|
|
$ |
4.08 |
|
|
|
3.4 |
|
|
$ |
1,274,287 |
|
| (1) |
Options with exercise prices ranging from $2.79 to $7.50 |
| (2) |
Options with exercise prices ranging from $2.79 to $7.29 |
| (3) |
The intrinsic value of a stock option is the amount by which
the market value of the underlying stock exceeds the exercise price of the option. |
|